# Phase 1 Study(Additional) of URC102 in Healthy Subjects

> **NCT02524678** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** URC102

## Key facts

- **NCT ID:** NCT02524678
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2015-10-07
- **Final completion:** 2016-03-28
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524678, "Phase 1 Study(Additional) of URC102 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02524678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*